- Cetrimide
-
- $0.00 / 25KG
-
2024-09-06
- CAS:1119-97-7
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 50000KG/month
|
| | Tetradecyltrimethylammonium bromide Chemical Properties |
| Melting point | 245-250 °C(lit.) | | density | 1.1328 (rough estimate) | | vapor pressure | 0Pa at 25℃ | | refractive index | 1.5260 (estimate) | | storage temp. | Store below +30°C. | | solubility | H2O: 10 % (w/v) | | form | Fine Crystalline Powder | | color | White | | PH | pH (50g/l, 25℃ : 4.0～6.0 | | Water Solubility | 20 g/100 mL | | Sensitive | Hygroscopic | | λmax | λ: 240 nm Amax: ≤0.08
λ: 250 nm Amax: ≤0.05
λ: 260 nm Amax: ≤0.04
λ: 500 nm Amax: ≤0.02 | | Merck | 14,6336 | | BRN | 3633227 | | Stability: | Stable. Hygroscopic. Incompatible with strong oxidizing agents. | | InChIKey | CXRFDZFCGOPDTD-UHFFFAOYSA-M | | LogP | 2.2 at 20℃ | | CAS DataBase Reference | 1119-97-7(CAS DataBase Reference) | | EPA Substance Registry System | |
| Hazard Codes | C | | Risk Statements | 34 | | Safety Statements | 26-36/37/39-45-27 | | RIDADR | UN 3263 8/PG 2 | | WGK Germany | 3 | | RTECS | BS5776000 | | F | 3 | | TSCA | Yes | | HazardClass | 8 | | PackingGroup | II | | HS Code | 29239000 | | Toxicity | LD50 in mice, rats (mg/kg): 12.0, 15.0 i.v. (Issomaa, Bjondahl) |
| Provider | Language |
|
| English |
|
| English |
|
| English |
| | Tetradecyltrimethylammonium bromide Usage And Synthesis |
| Physical properties | Cetrimide is a white fine powder crystal with a melting point of 245°C
to 250°C. A rough estimate of its density is 1.1328. It is soluble in
water with a solubility of 20 g/100 mL. | | Description | MiTMAB (1119-97-7) is a dynamin I/II inhibitor targeting the dynamin-phospholipid interaction and inhibiting dynamin GTPase activity with a Ki=940nM.1 Rapidly and reversibly inhibits multiple forms of endocytosis with no acute cellular damage1. A useful pharmacological tool for studying dynamin-mediated trafficking events.2 Induces cytokinesis failure and apoptosis in human cancer cells.3 Induces cytoprotective autophagy in human Jurkat T cells.4 | | Uses | Myristyltrimethylammonium has been used in a study to assess a surfactant-controlled synthetic method to obtain a nanophase of mesoporous ceria-zirconia solid solution containing cationic defects in the crystalline structure.??It has also been used in a study to determine the low molecular weight of organic acids in soils and plants by capillary zone electrophoresis. | | Uses | Disinfectant; deodorant; laboratory reagent. | | Definition | Myristyltrimethylammonium bro-mide. | | General Description | Myristyltrimethylammonium bromide is a cationic/zwitterionic type of surfactant. | | Purification Methods | Crystallise the bromide from acetone or a mixture of Me2CO and >5% MeOH or Me2CO/EtOH. Wash it with diethyl ether and dry it in a vacuum oven at 60o. It is a cationic detergent. Its solubility is 1g/5g H2O. [Dearden & Wooley J Phys Chem 91 2404 1987, Shelton et al. J Am Chem Soc 68 754 1946, Beilstein 4 III 419, 4 IV 813.] | | References | 1) Quan et al. (2007), Myristal trimethyl ammonium bromide and octadecyl trimethyl ammonium bromide are surface-active small molecules dynamin inhibitors that block endocytosis mediated by dynamin I or dynamin II; Mol. Pharmacol., 72 1425
2) Joshi et al. (2011), Development and validation of a stability indicating method for the enantioselective estimation of omeprazole enantiomers in the enteric-coated formulations by high performance liquid chromatography; Mol. Cancer, 104 78
3) De Beco et al. (2009), Endocytosis is required for E-cadherin redistribution at mature adherens junctions; Proc. Natl. Acad. Sci. USA, 106 7010
4) Kim et al. (2016), Inhibition of autophagy enhances dynamin inhibitor-induced apoptosis via promoting Bak activation and mitochondrial damage in human Jurkat T cells; Biochem. Biophys. Res. Commun., 478 1609 |
| | Tetradecyltrimethylammonium bromide Preparation Products And Raw materials |
|